Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Infect Dis. 2012 Jun;25(3):243-9. doi: 10.1097/QCO.0b013e328352f727.

Vaccination and herd immunity: what more do we know?

Author information

1
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead and The University of Sydney, Sydney, Australia.

Abstract

PURPOSE OF REVIEW:

This review summarizes herd immunity, focusing on conceptual developments with application to vaccination programs.

RECENT FINDINGS:

The conventional idea of herd immunity is based on the relationship between the transmission dynamics of infectious agents and population immunity. However, there have been some recent conceptual developments in vaccine 'herd immunity' or 'herd protection' that address the complexities of imperfect immunity, heterogeneous populations, nonrandom vaccine uptake and 'freeloaders'. Some vaccines may provide better protection than others; for instance, meningococcal conjugate vaccines are superior to polysaccharide vaccines, as is true of pneumococcal and Haemophilus influenzae type b vaccines. Achieving a very high uptake rate should be the target for certain vaccines, for example, measles vaccine, in order to prevent the disease effectively. Emerging issues, for example, waning of immunity after pertussis vaccination, are fresh challenges.

SUMMARY:

Herd immunity is a complex issue inherent to a vaccine and the population receiving the vaccine. We have more to learn and apply.

PMID:
22561998
DOI:
10.1097/QCO.0b013e328352f727
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center